The Effectiveness of Prophylactic Antibiotics for Urethral Bulking
NCT ID: NCT06261736
Last Updated: 2025-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
70 participants
INTERVENTIONAL
2023-10-24
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study)
NCT06706362
Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder
NCT02044965
Antibiotic Prophylaxis for Neurogenic Bladder Botox
NCT04791579
Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)
NCT01450800
Nitrofurantoin and Urinary Tract Infections (UTIs)
NCT00678041
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Antibiotic Group
Those randomized to this group will receive a one-time dose of an oral antibiotic prior to the urethral bulking procedure. The antibiotic will be based on the participants' allergies, medical history, and current medication list.
Prophylactic antibiotics
These participants will be given a single dose of an oral antibiotic prior to the procedure.
No antibiotic group
Those randomized to this group will not receive an antibiotic prior to the urethral bulking procedure.
No antibiotics
These participants will not be given an antibiotic prior to the procedure.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prophylactic antibiotics
These participants will be given a single dose of an oral antibiotic prior to the procedure.
No antibiotics
These participants will not be given an antibiotic prior to the procedure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 ≥ over
Exclusion Criteria
* Known history of urinary retention
* Allergies or contraindications to multiple antibiotics
* Inability to tolerate oral antibiotics
* Concomitant surgical procedures at the time of urethral bulking
* Pregnant or breastfeeding
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Atlantic Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erika Wasenda
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erika Wasenda, MD
Role: PRINCIPAL_INVESTIGATOR
Atlantic Health System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Atlantic Health
Morristown, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2107044-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.